Seeing Is Believing
Currently, out of the existing stock ratings of David Evans - 1 which are a Buy (100%)
Analyst David Evans works at KEPLER CHEUVREUX and is covering the Healthcare sector with 2 price targets and ratings displayed on 1 stocks.
David Evans's average stock forecast success ratio is 100% with an average time for price targets to be met of 209 days.
Most recent stock forecast was given on NVS, Novartis AG at 07-Sep-2022.
Analyst best performing recommendations are on NVS (NOVARTIS AG).
The best stock recommendation documented was for NVS (NOVARTIS AG) at 9/7/2022. The price target of $92.78 was fulfilled within 209 days with a profit of $15.21 (19.61%) receiving and performance score of 0.94.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
95.11
4 months 20 days ago
14/14 (100%)
$8.91 (12.17%)
370
Hold
89.89
6 months 21 days ago
2/2 (100%)
$12.47 (23.31%)
674
Buy
117.2
$20.9 (21.70%)
112
7 months 7 days ago
1/3 (33.33%)
$19.16 (22.52%)
504
Sell
105.18
$8.88 (9.22%)
98.55
7 months 13 days ago
10/16 (62.5%)
$18.32 (23.03%)
543
Hold
90
$-6.3 (-6.54%)
87.2
7 months 13 days ago
6/10 (60%)
$2.57 (3.94%)
293
What Year was the first public recommendation made by David Evans?